Across TCGA pan-cancer cohorts, MIR3945HG RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MIR3945HG data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR3945HG RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3945HG expression acts as an unfavorable survival marker, although some lineages such as SKCM and LIHC show a favorable association.
KIRC, THYM, and LGG are the cancer types where MIR3945HG RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.